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I nfluenza is a representative viral infection,  typi-cally causing an acute-onset high fever accompa-
nied by upper and lower respiratory symptoms such as 
nasal discharge,  sore throat,  and cough.  According to 
the statistics from the Ministry of Health,  Labour,  and 
Welfare in Japan,  > 10 million cases of influenza have 
been reported per year in recent years,  while 12 million 
cases [1] were reported in the 2018–2019 season,  with 
3,400 deaths [2].  The majority of excess mortality in 
Japan (the extent to which influenza and pneumonia 
deaths have increased as a result of the influenza epi-
demic) [3] was reported in older adults and those who 
were complicated with cerebrovascular diseases [4].  
This finding indicates that influenza will have a great 
impact on older populations in the hyper-aging society 
in Japan.
In general,  anti-influenza medication is not neces-
sary for young healthy adults infected with influenza 
because the disease eventually resolves during its course 
[5].  In contrast,  older adults tend to develop more 
severe disease than younger adults and have a higher 
incidence of complications such as pneumonia [6].  In 
fact,  80-90% of influenza deaths occurred in individu-
Acta Med.  Okayama,  2021
Vol.  75,  No.  5,  pp.  567-574
CopyrightⒸ 2021 by Okayama University Medical School.
http ://escholarship.lib.okayama-u.ac.jp/amo/Original Article
Clinical Manifestations of Patients with Influenza Differ by Age:  
A Prospective,  Multi-centered Study in the Setouchi Marine Area
Ryosuke Takase,  Hideharu Hagiya＊,  Hiroyuki Honda,  Yasuhiro Nakano,   
Hiroko Ogawa,  Mikako Obika,  Keigo Ueda,  Hitomi Kataoka,   
Yoshihisa Hanayama,  and Fumio Otsuka
Department of General Medicine,  Okayama University Graduate School of Medicine,   
Dentistry and Pharmaceutical Sciences,  Okayama 700-8558,  Japan
Influenza potentially has a high mortality rate when it affects the elderly.  We aimed to examine the differences 
in clinical manifestations in patients with influenza according to their age.  This multicenter prospective study 
was performed in six medical institutions in Okayama and Kagawa prefectures (Japan).  Between December 1,  
2019 and March 31,  2020,  we collected data on adult patients diagnosed with influenza type A,  who were strat-
ified into younger (20-49 years),  middle-aged (50-64 years),  and older groups (≥ 65 years).  We compared the 
presence or absence of fever,  respiratory symptoms,  and extrapulmonary symptoms according to age group.  In 
total,  203 patients (113,  younger; 51,  middle-aged; and 39,  older) were eligible for the analysis.  The maxi-
mum body temperature and temperature at first physician visit in the older group were significantly lower than 
those in the younger group.  The incidence of respiratory symptoms was not different among the three groups.  
Chills,  muscle pain,  and arthralgia as systemic symptoms were noted significantly more frequently in the 
younger (80.9%) and middle-aged (75.5%) groups than in the older group (51.3%) (p= 0.002).  Fever and sys-
temic symptoms were less likely to appear in older patients,  possibly resulting in the delaying of hospital visits 
among older adults.
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als aged ≥ 65 years [7].  However,  the clinical symptoms 
of influenza in the elderly are less apparent or atypical,  
and early diagnosis is difficult in some cases because the 
symptoms in the elderly can be vague [8].  From the 
perspective of preventing the spread of infection,  it is 
also important to establish a diagnosis as early as possi-
ble,  especially in hospitals and nursing homes in Japan,  
where the population is aging rapidly.
The differences in influenza symptoms between 
younger and older populations remain unclear.  
According to a study on patients with influenza A in 
nursing homes,  upper respiratory symptoms such as 
sore throat and nasal discharge occurred less frequently 
in the elderly than in the younger adults,  while lower 
respiratory symptoms such as cough and sputum 
tended to appear at a higher frequency [9].  However,  
few studies have investigated the differences in the 
symptoms of influenza by age.  This study aimed to 
examine and analyze whether the appearance of influ-
enza-related symptoms differs according to age.
Patients and Methods
This was a multicenter prospective study of patients 
who visited the outpatient clinics in six medical institu-
tions in Okayama and Kagawa prefectures in Japan 
(Marugame Medical Center,  Kasaoka City Hospital,  
Bizen City National Health Insurance Hospital,  
Tamano City Hospital,  Okayama Kinen Hospital,  and 
Niimi National Health Insurance Yukawa Clinic) 
between December 1,  2019 and March 31,  2020.  Apart 
from Niimi National Health Insurance Yukawa Clinic,  
all of these institutions are local general hospitals with 
inpatient beds.  The study protocol was approved by the 
institutional review board of Okayama University 
Hospital (Approval No. 1908-017),  with prior approval 
from each institution.
During the influenza pandemic season in Japan,  
men and women aged 20 years old or older who were 
suspected of having influenza were included in the 
study.  They were asked to complete a questionnaire- 
based medical interview sheet to obtain information on 
the following items: 1) age and gender; 2) vaccination 
status during the season; 3) axillary body temperature 
at maximum and at first physician visit; 4) clinical 
symptoms such as nasal symptoms (nasal discharge,  
nasal obstruction,  and sneezing),  pharyngeal symp-
toms (sore throat,  dysphagia,  and hoarseness),  lower 
respiratory tract symptoms (cough and sputum),  sys-
temic symptoms (chills,  muscle pain,  and arthralgia),  
headache,  and gastrointestinal symptoms (nausea and 
diarrhea); and 5) time from disease onset to first phy-
sician visit.  Written informed consent was obtained 
from every patient when they answered the self-admin-
istered questionnaire.
Patients who were diagnosed with influenza type A 
using influenza rapid antigen tests were included in the 
analysis,  because influenza type A,  not type B,  is the 
major type that causes a pandemic every year in Japan.  
The eligible patients were divided into three age groups 
(younger group,  20-49 years; middle-aged group,  
50-64 years; and older group,  ≥ 65 years).  The primary 
endpoint was defined as the presence or absence of fever 
and respiratory symptoms,  while the secondary end-
point was the presence of extrapulmonary symptoms 
(general symptoms,  headache,  and gastrointestinal 
symptoms).  We also investigated the time from disease 
onset to first physician visit.  These endpoints were 
compared among the three age groups for analysis.
Statistical analyses were performed using the 
Kruskal-Wallis test and the Mann-Whitney U-test 
(Bonferroni correction) for continuous variables and 
Fisher’s exact test for categorical variables.  Also,  to 
analyze the correlation between age and body tempera-
ture,  Spearman’s rank correlation test was performed.  
All statistical analyses were performed using EZR soft-
ware based on R (version 3.5.2).  Statistical significance 
was set at p < 0.05.
Results
During the study period,  the clinical data of 1,140 
patients were collected.  Among these patients,  220 
were diagnosed with influenza using the rapid influenza 
antigen test,  of whom 207 had influenza type A and 13 
had influenza type B.  After excluding 4 patients with 
missing data,  203 were included in the final analysis 
(Fig. 1).
The background data of patients according to age 
group are summarized in Table 1.  The patients’ ages 
ranged from 20 to 93 years,  with a median age of 45.5 
years.  Overall,  114 men and 89 women were included.  
The numbers of patients in the younger,  middle-aged,  
and older groups were 113,  51,  and 39,  respectively.  
The in-season vaccination rate in the older group was 
significantly higher (64.7%) than in the younger (29.9%) 
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and middle-aged (27.9%) groups (p = 0.001).
The clinical manifestations of the patients in each age 
group are also shown in Table 1.  The overall mean 
(± standard deviation) maximum body temperature was 
38.4 ± 0.9°C (younger group,  38.5 ± 0.9°C; middle-aged 
group,  38.3 ± 0.9°C; and older group,  38.2 ± 0.7°C).  
The overall mean temperature at first physician visit was 
37.7 ± 0.9°C (younger group,  37.8 ± 0.9°C; middle-aged 
group,  37.5 ± 1.1°C; and older group,  37.4 ± 0.9°C).  
The proportions of patients whose maximum body tem-
perature and temperature at first physician visit were 
both < 37°C were 3.0%,  9.5%,  and 6.1% in the younger,  
middle-aged,  and older groups,  respectively.  Similarly,  
the proportions of those whose maximum body tem-
perature and temperature at first physician visit were 
both < 37.5°C were 13.0%,  19.0%,  and 15.2% in the 
younger,  middle-aged,  and older groups,  respectively.  
Of 34 elderly patients,  the median ages of vaccinated (7 
men and 15 women) and unvaccinated (7 men and 5 
women) individuals were 74.5 years and 72.8 years,  
respectively.  The maximum body temperatures in the 
vaccinated (N = 20) and unvaccinated patients (N = 10) 
were 38.0 ± 0.7°C and 38.4 ± 0.4°C, respectively 
(p = 0.07).  Also,  the body temperatures at first physi-
cian visit in the vaccinated and unvaccinated patients 
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Table 1　 Backgrounds and clinical manifestations of the patients diagnosed with influenza type A





Total number of the cases 203 113 51 39
(A) Background
Age,  median [IQR] 45.5 [35,  58] 37 [30,  43] 56 [52,  58] 72 [68,  77]
Sex M/F 114/89 68/45 29/22 17/22
Vaccination rate (%) 35.9 (66/184) 29.9 (32/107)＊ 27.9 (12/43)＊ 64.7 (22/34)＊ 0.0012)
(B) Manifestations
Body temperature,  mean±SD
　　Maximum 38.4±0.9 (182) 38.5±0.9 (103) 38.3±0.9 (44) 38.2±0.7 (35) 0.0581)
　　At first physician visit 37.7±0.9 (195) 37.8±0.9 (109)＊ 37.5±1.1 (49) 37.4±0.9 (37)＊ 0.0311)
Respiratory symptoms (%)
　　Nasal 66.7 (134/201) 69.6 (78/112) 62.8 (32/51) 63.2 (24/38) 0.6232)
　　Pharyngeal 71.9 (146/203) 76.1 (86/113) 72.6 (37/51) 59.0 (23/39) 0.122)
　　Lower respiratory 86.6 (175/202) 90.3 (102/113) 80.4 (41/51) 84.2 (32/38) 0.742)
Systemic symptoms† (%) 73.7 (146/198) 80.9 (89/110)＊ 75.5 (37/49)＊ 51.3 (20/39)＊ 0.0022)
Headache (%) 63.3 (124/196) 67.6 (73/108) 60.8 (31/51) 54.1 (20/37) 0.3072)
Gastrointestinal symptoms†† (%) 11.0 (22/200) 12.7 (14/110) 11.8 (6/51) 5.1 (2/39) 0.4422)
IQR,  interquartile range; SD,  standard deviation.  †Chills,  muscle,  and joint pain; ††Nausea and diarrhea.
Numbers in the parenthesis indicate the number of cases that were available.  ＊Shows the groups in which statistical significance was 
observed.
1)Kruskal-Wallis test; 2)Fisherʼs exact test.
Some data were missing because it was obtained by self-administered questionnaire.
Patients who was suspected as influenza (n=1,140)
Marugame Medical Center (n=393)
Kasaoka City Hospital (n=414)
Bizen City National Health Insurance Hospital  (n=142)
Tamano City Hospital (n=143)
Okayama Kinen Hospital (n=42)
Niimi National Health Insurance Yukawa Clinic (n=6)
Total of 220 cases analyzed
diagnosed wit influenza A (n=207)






Negative in Rapid antigen test
Excluded
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Fig. 1　 Outline of the study.
were 37.3 ± 0.7°C (N = 20) and 37.3 ± 1.0°C (N = 12),  
respectively (p = 0.85).
The correlations between age and body temperature 
showed that older patients were less likely to have ele-
vated body temperatures.  Spearman’s correlation anal-
ysis showed inverse correlations between age and the 
maximum body temperature (p= 0.005) and between age 
and temperature at first physician visit (p < 0.001) 
(Fig. 2).  That is,  the older the patient,  the lower the 
body temperature.  To investigate the influence of vacci-
nation on the body temperature,  we subdivided the data 
into those vaccinated and those unvaccinated or 
unknown.  For maximum body temperature,  the vacci-
nated patients had a stronger correlation coefficient of 
−0.28 compared with the unvaccinated patients (cor-
relation coefficient; −0.12),  though there was no sig-
nificant difference.  As for the body temperature at first 
physician visit,  the vaccinated also had a stronger cor-
relation coefficient of −0.29 (p = 0.026) compared with 
the unvaccinated (correlation coefficient; −0.17).
The respiratory tract manifestations of the study 
patients are shown in Table 1 as well.  Nasal,  pharyn-
geal,  and lower respiratory symptoms were observed in 
66.7%,  71.9%,  and 86.6% of the patients,  respectively.  
Among the three age groups,  the incidences of respira-
tory symptoms did not show any significant differences.  
The different parts of the respiratory system (nasal,  
pharyngeal,  or lower respiratory tract) where the 
symptoms occurred are summarized in Fig . 3.  The pro-
portions of patients in the younger,  middle-aged,  and 
older groups with no respiratory symptoms were 1.8%,  
3.9%,  and 7.7%,  respectively.  These ratios increased as 
the number of respiratory areas involved increased in 
each age group.  All three areas were involved in 52.2%,  
39.2%,  and 41.0% of the younger,  middle-aged,  and 
older groups,  respectively,  indicating that older indi-
viduals tended to manifest limited respiratory symp-
toms.
Systemic symptoms such as chills,  muscle pain,  and 
arthralgia were reported in 80.9% and 75.5% of the 
patients in the younger and middle-aged groups,  
respectively,  and these percentages were significantly 
higher than the percentage of patients in the older group 
with systemic symptoms (51.3%) (p = 0.002).  Headache 
and gastrointestinal symptoms were found in 63.3% 
and 11.0% of the patients,  respectively.  However,  no 
statistical differences were found among the three age 
groups (Table 1).
570 Takase et al. Acta Med.  Okayama　Vol.  75,  No.  5














































Fig. 2　 Correlation between age and maximum body temperature (A) and temperature at first physician visit (B).  Statistical analyses 
were performed using Spearmanʼs rank correlation test.  The case numbers of the vaccinated (white dots),  the unvaccinated (black dots),  
and unknown vaccination status (gray dots) in the maximum body temperature (A) were 61,  103,  and 18,  respectively.  The case numbers 
in the temperature at first physician visit (B) were 61,  115,  and 19,  respectively.  The correlation coefficients for (i) overall,  (ii) the vacci-
nated (white dots),  and (iii) the unvaccinated (black dots) for (A) maximum body temperature were (i) －0.206 (p=0.005),  (ii) －0.28 
(p=0.082),  and (iii) －0.12 (p=0.248).  Similarly,  those for (B) body temperature at first physician visit were (i) －0.235 (p<0.001),  (ii) 
－0.29 (p=0.026),  and (iii) －0.17 (p value,  0.069).
The time from disease onset to first physician visit is 
shown in Fig. 4.  In the younger group,  74.5%,  17.0%,  
and 8.5% of the patients visited a hospital within 1 day,  
after 1-2 days,  and after ≥ 3 days,  respectively.  In the 
middle-aged group,  60.0%,  28.0%,  and 12.0% of the 
patients visited a hospital within 1 day,  after 1-2 days,  
and after ≥ 3 days,  respectively.  In the older group,  
44.1%,  26.5%,  and 29.4% of the patients visited a hos-
pital within 1 day,  after 1-2 days,  and after ≥ 3 days,  
respectively.  These data suggest that older people 
tended to visit a hospital for consultation in a later 
phase after the disease onset.
Discussion
This study revealed the following three characteris-
tics of influenza infection in the elderly compared with 
younger age groups: (i) the elderly were less likely to 
have elevated body temperatures; (ii) the elderly were 
less likely to have respiratory and systemic symptoms;  
and (iii) the elderly tended to visit a hospital compara-
tively later than younger individuals.
First,  we found that older people appeared to expe-
rience a lower-grade fever when infected with an influ-
enza virus.  The typical presentations of patients with 
influenza are acute-onset high fever accompanied by 
systemic symptoms and a wide range of respiratory 
symptoms.  The World Health Organization definition 
of influenza also lists acute-onset high fever above 38°C 
and cough as clinical features suggesting influenza [10].  
In a previous study examining the clinical symptoms 
and pretest probabilities of influenza in primary care 
settings,  the absence of cough and fever > 37.8°C was 
reported to be useful in excluding individuals with 
influenza infections,  although the median age of the 
participants in that study was relatively low (27-28 
years) [11].  In general,  however,  as people age,  they 
tend to be afebrile and asymptomatic when they 
develop an infectious disease [12].  According to a pre-
vious study from Japan,  13.6% of patients aged ≥ 65 
years with influenza type A showed a maximum body 
temperature < 37.5°C [8].  A similar tendency was also 
observed in our study,  in which 17.9% of the patients 
aged ≥ 65 years had a temperature of < 37.5°C.  Our cor-
relation analysis revealed that the body temperature 
decreased as the age of the patients progressed.  From 
these findings,  we conclude that older people infected 
with influenza present a lower grade fever compared 
with young people.  However,  a comparison of those 
with and without an influenza vaccination revealed that 
the inverse correlation between age and fever was stron-
ger in the vaccinated group.  The vaccination rates in our 
cohort were significantly higher in the elderly,  and this 
fact could have resulted in the smaller body tempera-
ture elevation observed in the elderly.
Second,  respiratory and systemic symptoms were 
also less likely to occur in the elderly.  Patients with 
influenza usually experience nasal,  pharyngeal,  and 
cough symptoms; e.g.,  according to a previous study in 
which 86.8% of the individuals had influenza type A,  
with a mean age of 34.8 years,  91%,  84%,  and 93% of 

























Fig. 3　 The numbers of respiratory areas (nasal,  pharyngeal,  or 
lower respiratory tract) where the symptoms occurred,  by age group.  
The number of infectious sites (horizontal axis) indicates the num-
ber of respiratory areas (either nasal,  pharyngeal,  or lower respira-
tory) where the symptoms occurred.  The numbers of cases in the 






















Fig. 4　 Time from disease onset to first physician visit,  by age 
group.  The numbers of cases in the younger,  middle-aged,  and 
older groups were 106,  50,  and 34,  respectively.
these patients had nasal,  pharyngeal,  and cough symp-
toms,  respectively [13].  Practically,  the absence of 
these respiratory symptoms reportedly lowers the possi-
bility of influenza; the positive likelihood ratios of nasal 
congestion and cough for the diagnosis of influenza 
were 0.49 and 0.42,  respectively [14].  Accordingly,  a 
lack of these typical manifestations reduces the clinical 
implications of the disease,  possibly resulting in a delay 
in the diagnosis.  The present study showed that the 
elderly group tended to have fewer respiratory symp-
toms as well and were less likely to develop systemic 
symptoms than younger patients (Table 1 and Fig. 3).  
Lower respiratory tract symptoms tended to be present 
at a higher rate (84.2%) than other respiratory symp-
toms in the older population,  suggesting that the emer-
gence of cough or sputum may be a clue to suspect 
influenza in the elderly.  Similarly,  other studies also 
reported the diagnostic value of acute-onset fever 
accompanied by cough for the diagnosis of influenza in 
patients aged ≥ 60 years [14 , 15].  Compared with other 
viral infections,  influenza infection tends to involve a 
longer duration of fever,  possibly causing systemic 
symptoms such as headache,  muscular arthralgia,  and 
chills more frequently [16].  A previous report con-
cluded that the likelihood ratio of such systemic symp-
toms for the diagnosis of influenza was 2.6 (95% confi-
dence interval,  2.0-3.2) in patients aged ≥ 60 years [14].  
In contrast,  such systemic symptoms were present in 
only half of the patients in the older group,  indicating 
the difficulty of diagnosing influenza among aged indi-
viduals.  Apart from the typical manifestations,  it is 
important to focus on any decrease in activities of daily 
living in the elderly to increase the pre-test probability 
of influenza [17].
Third,  our study found that the time from disease 
onset to first physician visit was longer in the older 
group.  To the best of our knowledge,  no recent studies 
have compared this time interval among patients in dif-
ferent age groups.  We speculate that this difference may 
be due to various factors,  including the fact that the 
symptoms may have been less apparent in the older 
group as explained above,  as well as to the accessibility 
of hospitals and economic problems.  According to a 
study that described a case of nosocomial influenza in 
an acute hospital,  32% of the patients who had a body 
temperature of < 38°C were diagnosed ≥ 3 days from the 
disease onset [18].  In contrast,  patients presenting with 
a high fever of ≥ 38°C were diagnosed earlier.  Thus,  the 
higher the number of older patients with influenza,  the 
higher the possibility that influenza patients can be 
overlooked because of their latent symptoms.  As a mat-
ter of course,  if a patient is diagnosed at a later point in 
the disease course,  the risk of transmission to the sur-
rounding population increases.  Outbreaks of influenza 
can occur in both hospitals and nursing homes [9 , 18],  
and healthcare workers should be aware that many 
older adults with influenza only exhibit nonspecific 
symptoms.  In addition,  the other factors contributing 
to this time delay in seeking treatment,  such as hospital 
accessibility and economic problems among the elderly,  
should be addressed.  In this aging Japanese society,  a 
comprehensive administrative support system for the 
elderly must be established in order to increase their 
access to medical services.
Pathophysiological mechanisms that can explain the 
greater mortality rate of influenza in the elderly should 
be discussed.  Based on a global epidemiological study,  
the mortality rate of people < 65 years of age (1.0-
5.1/100,000) is apparently better than the rate of those 
aged 65-74 years (13.3-27.8/100,000) and those aged 
> 75 years (51.3-99.4/100,000) [19].  Generally,  the 
immune system weakens as humans age due to declines 
in humoral-,  and cell-mediated immunities.  In partic-
ular,  the cell-mediated immunity that is dependent on 
the balance between the subsets of helper T cells (Th1 as 
pro-inflammatory and Th2 as anti-inflammatory) is 
weakened with aging,  resulting in infectious diseases 
affecting the elderly with greater severity [20].  In addi-
tion,  reduced reactivity to specific pathogens is 
observed in the elderly as a result of the T cells in the 
thymus,  spleen,  and lymph nodes having less matura-
tion capacity in older individuals [21].  Dysregulation of 
the cytokine network as a geriatric phenomenon is also 
responsible for the deterioration of the response of 
innate and adaptive immune mechanisms.  It is known 
that a lower ratio of interferon-γ to interleukin-10 and 
lower levels of inducible granzyme B activity in the 
elderly are associated with high influenza mortality 
[22].  In addition to the molecular mechanisms,  aging 
can lead to physical weakness in the elderly,  with a 
reduced mucociliary clearance and decreased cough 
reflex resulting from sarcopenia [23].  All of these geri-
atric changes are potential contributing factors to the 
severity of influenza in the elderly.
There are some limitations to this study.  First,  anti-
gen tests,  but not polymerase chain reaction (PCR) 
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tests,  were conducted to diagnose influenza in this 
study.  Generally,  the sensitivity of the rapid antigen test 
is reported to be lower than that of the PCR tests [24],  
and the cases could have been underdiagnosed.  Second,  
the clinical data were obtained using self-administered 
questionnaires,  for which there could potentially be a 
recall bias.  Third,  it was not determined whether or not 
the patients took any medications to ameliorate the 
symptoms before the consultation.  Fourth,  although 
the study aimed to examine the differences in clinical 
symptoms between younger and older populations,  
only 39 individuals aged ≥ 65 years were eligible for the 
study.  This could be attributed to the fact that the study 
was performed amid the coronavirus disease 2019 
(COVID-19) pandemic in Japan,  and the influenza epi-
demic in this period might have differed from the epi-
demics reported in previous years.  We assume that 
older people refrained from going outside during the 
study period,  which may have led to a delay or avoid-
ance of hospital visits.  Fifth,  the vaccination rates were 
different among the age groups (higher in older people),  
which could have influenced the clinical manifestations 
because the vaccine effectively reduced the severity of 
the condition and prevented the disease from becoming 
severe [25].  Finally,  some patients might have visited 
other outpatient clinics before visiting our facilities,  but 
this was not investigated in the questionnaire survey.
In summary,  our study found that clinical manifes-
tations,  including fever,  respiratory,  and systemic 
symptoms,  in older patients infected with influenza 
were less apparent compared with those in younger 
individuals.  In addition,  the time from disease onset to 
first physician visit tended to be longer in older patients.  
These characteristics of influenza in the elderly may 
result in a delayed diagnosis in the aged population,  
possibly causing delays in treatment and thus the devel-
opment of secondary complications.  From the perspec-
tive of infection prevention,  the latent manifestation of 
influenza among the elderly increases the risk of the 
rapid spread of the infection among elderly individuals,  
such as those in nursing homes and chronic care facili-
ties.  During the influenza epidemic season,  even in the 
absence of fever and respiratory symptoms,  clinicians 
should suspect influenza with a low threshold of doubt 
in elderly patients and should proactively perform a 
specific test to diagnose the infection in order to pro-
vide early treatment and prevent further epidemics in 
the older population.  Patients with COVID-19 can also 
be asymptomatic; hence,  diagnoses of viral diseases 
must be established without relying solely on the 
patient’s clinical manifestations.  General practitioners 
should further inform the public,  especially elderly 
people,  of the importance of seeing a doctor without a 
delay when they feel that their condition is unusual,  
even in the absence of typical manifestations.
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